Acceptability, usability, and willingness to pay for HIV self-test kits distributed through community-based, PLHIV network-led and private practitioners models in India: Results from the STAR III Initiative.


Journal

Journal of the International AIDS Society
ISSN: 1758-2652
Titre abrégé: J Int AIDS Soc
Pays: Switzerland
ID NLM: 101478566

Informations de publication

Date de publication:
Aug 2024
Historique:
received: 18 01 2024
accepted: 25 07 2024
medline: 9 8 2024
pubmed: 9 8 2024
entrez: 9 8 2024
Statut: ppublish

Résumé

HIV self-testing (HIVST) has been shown to increase the uptake of HIV testing and help achieve the UNAIDS 95-95-95 targets. This study assessed the acceptability, usability (ease of use and result interpretation) and the willingness to pay for HIVST kits distributed through three distribution models, namely the community-based, PLHIV network-led and private practitioners models, in India. This cross-sectional study was implemented across 14 states in India between September 2021 and June 2022. All participants could choose between blood-based or oral-fluid-based test kits. Participants were shown a test-kit usage demonstration video, and pre- and post-test counselling was provided for all. Participants were followed-up after testing, and if reported reactive, were further supported for linkage to confirmatory testing and antiretroviral therapy (ART) initiation. Among the 90,605 participants found eligible, 88,080 (97%) accepted an HIVST kit. Among the 87,976 who reported using an HIVST kit, 45,207 (51%) preferred a blood-based kit, and 42,120 (48%) reported testing for the first time. For future testing, 77,064 (88%) reported preferring HIVST over other HIV testing methods. Among those who used the kit, 83,308 (95%) found the kit easy to use, and 83,237 (95%) reported that the test results were easy to interpret. Among those who preferred HIVST for future use, 52,136 (69%) were willing to pay for the kit, with 35,854 (69%) of those willing to pay less than US$ 1.20. Only one instance of social harm was reported, with a participant reporting suicidal tendencies due to discord with their partner. Out of 328 participants (0.4%) who tested reactive with HIVST, 291 (89%) were linked to confirmatory testing; of these, 254 were confirmed HIV positive, and 216 (85%) successfully initiated ART. Overall, we report that nearly all participants were willing to accept HIVST, found the test kits easy to use and interpret, and about two-thirds were willing to pay for HIVST. Given the high levels of acceptance and the ability to reach a large proportion of first-time testers, HIVST in India could contribute to achieving the UNAIDS first 95 and ending the HIV epidemic.

Identifiants

pubmed: 39118294
doi: 10.1002/jia2.26348
doi:

Substances chimiques

Reagent Kits, Diagnostic 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e26348

Informations de copyright

© 2024 The Author(s). Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of International AIDS Society.

Références

UNAIDS. Factsheet 2022. Accessed 12 Feb 2023. https://www.unaids.org/sites/default/files/media_asset/UNAIDS_FactSheet_en.pdf
National AIDS Control Organisation. Sankalak: Status of National AIDS Response (5th edition). New Delhi; 2023.
Hatzold K, Gudukeya S, Mutseta MN, Chilongosi R, Nalubamba M, Nkhoma C, et al. HIV self‐testing: breaking the barriers to uptake of testing among men and adolescents in sub‐Saharan Africa, experiences from STAR demonstration projects in Malawi, Zambia and Zimbabwe. J Int AIDS Soc. 2019;22(Suppl 1):e25244. https://doi.org/10.1002/jia2.25244/full
World Health Organization. Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach. Geneva; 2021.
Witzel TC, Eshun‐Wilson I, Jamil MS, Tilouche N, Figueroa C, Johnson CC, et al. Comparing the effects of HIV self‐testing to standard HIV testing for key populations: a systematic review and meta‐analysis. BMC Med. 2020;18:1–13.
Johnson CC, Kennedy C, Fonner V, Siegfried N, Figueroa C, Dalal S, et al. Examining the effects of HIV self‐testing compared to standard HIV testing services: a systematic review and meta‐analysis. J Int AIDS Soc. 2017;20(1):21594.
National AIDS Control Organization. National AIDS and STD Control Programme Phase‐V (2021–2026). Anchoring the national response towards ending the AIDS epidemic. 2022.
Rawat S, Solomon SS, Dange A, Srikrishnan AK, Chakrapani V, Mohan B, et al. Community perspectives on making HIV self‐testing accessible as a comprehensive prevention package. New York: Springer; 2018.
Rao A, Patil S, Aheibam S, Kshirsagar P, Hemade P, Panda S. Acceptability of HIV oral self‐test among men having sex with men and transgender population: a qualitative investigation from Pune, India. Infect Dis (Auckl). 2020;13:1178633720962809. doi: 10.1177/1178633720962809
Rao A, Patil S, Kulkarni PP, Devi AS, Borade SS, Ujagare DD, et al. Acceptability of HIV oral self‐test among truck drivers and youths: a qualitative investigation from Pune, Maharashtra. BMC Public Health. 2021;21:1931.
Rao A, Patil S, Nirmalkar A, Bagul R, Ghule U, Panchal N, et al. HIV oral self‐screening test among HIV/STD/TB clinic attendees: a mixed‐method pilot investigation examining merit for larger evaluation. Indian J Med Res. 2022;155:403–412.
Chang YM, Sevekari T, Duerr A, Molina Y, Gilada T. HIV self‐testing in Pune, India: perspectives and recommendations of female sex workers and peer educators. AIDS Care. 2020;32:182–185.
Vashisht S, Rai S, Kant S, Halder P, Misra P, Goswami K, et al. Oral HIV self‐testing among men who have sex with men in New Delhi, India: perceptions & apprehensions: a qualitative study. Indian J Med Res. 2022;156(6):764–770. https://doi.org/10.4103/ijmr.ijmr_718_22
Sarkar A, Mburu G, Shivkumar PV, Sharma P, Campbell F, Behera J, et al. Feasibility of supervised self‐testing using an oral fluid‐based HIV rapid testing method: a cross‐sectional, mixed method study among pregnant women in rural India. J Int AIDS Soc. 2016;19:20993.
Westreich D, Greenland S. The table 2 fallacy: presenting and interpreting confounder and modifier coefficients. Am J Epidemiol. 2013;177:292–298.
Qin Y, Tang W, Nowacki A, Mollan K, Reifeis SA, Hudgens MG, et al. Benefits and potential harms of human immunodeficiency virus self‐testing among men who have sex with men in China: an implementation perspective. Sex Transm Dis. 2017;44:233–238.
Hatzold K, Gudukeya S, Mutseta MN, Chilongosi R, Nalubamba M, Nkhoma C, et al. HIV self‐testing: breaking the barriers to uptake of testing among men and adolescents in sub‐Saharan Africa, experiences from STAR demonstration projects in Malawi, Zambia and Zimbabwe. J Int AIDS Soc. 2019;22:e25244.
Green KE, Vu BN, Phan HT, Tran MH, Ngo HV, Vo SH, et al. From conventional to disruptive: upturning the HIV testing status quo among men who have sex with men in Vietnam. J Int AIDS Soc. 2018;21:e25127.
Department of Health & Family Welfare Ministry of Health & Family. Annual Report 2021–22. 2022.
Ashburn K, Antelman G, N'Goran MK, Jahanpour O, Yemaneberhan A, N'Guessan Kouakou B, et al. Willingness to use HIV self‐test kits and willingness to pay among urban antenatal clients in Cote d'Ivoire and Tanzania: a cross‐sectional study. Trop Med Int Health. 2020;25:1155–1165.
Thirumurthy H, Masters SH, Agot K. Willingness to pay for HIV self‐tests among women in Kenya: implications for subsidy and pricing policies. J Acquir Immune Defic Syndr. 2018;78:E8–E11.
Tonen‐Wolyec S, Kayembe Tshilumba C, Batina‐Agasa S, Marini Djang'eing'a R, Hayette MP, Belec L. Comparison of practicability and effectiveness between unassisted HIV self‐testing and directly assisted HIV self‐testing in the Democratic Republic of the Congo: a randomized feasibility trial. BMC Infect Dis. 2020;20:1–10.
Ngoc BV, Majam M, Green K, Tran T, Hung MT, Que AL, et al. Acceptability, feasibility, and accuracy of blood‐based HIV self‐testing: a cross‐sectional study in Ho Chi Minh City, Vietnam. PLOS Glob Public Health. 2023;3:e0001438.
West RL, Freeman L, Pahe C, Momanyi H, Kidiga C, Malaba S, et al. Characterising the HIV self‐testing market in Kenya: awareness and usage, barriers and motivators to uptake, and propensity to pay. PLOS Glob Public Health. 2023;3:e0001776.
Unitaid, World Health Organization. Market and technology landscape: HIV rapid diagnostic tests for self‐testing (4th edition). Geneva; 2018.
Pandya AK, Redcay A. Access to health services: barriers faced by the transgender population in India. J Gay Lesbian Ment Health. 2021;25:132–154.

Auteurs

Asha Hegde (A)

PATH, Mumbai, India.

Alpana Dange (A)

The Humsafar Trust, Mumbai, India.

Kannan Mariyappan (K)

PATH, Mumbai, India.

Manish Soosai (M)

Solidarity and Action Against The HIV Infection in India (SAATHII), Chennai, India.

Sandeep Mane (S)

The Humsafar Trust, Mumbai, India.

Murugesan Sivasubramanian (M)

The Humsafar Trust, Mumbai, India.

Mahesh Doddamane (M)

Solidarity and Action Against The HIV Infection in India (SAATHII), Chennai, India.

Madhuri Mukherjee (M)

International Training and Education Centre for Health (I-TECH), New Delhi, India.

G S Shreenivas (GS)

PATH, Mumbai, India.

Manoj Pardesi (M)

National Coalition of People Living with HIV in India (NCPI+), New Delhi, India.
Network of Maharashtra By People Living With HIV/AIDS (NMP+), Pune, India.

Vinod Jambhale (V)

Network of Maharashtra By People Living With HIV/AIDS (NMP+), Pune, India.

Venkateswara Rao Pakkela (V)

Voluntary Health Services (VHS), Chennai, India.

Vijayaraman Arumugam (V)

Voluntary Health Services (VHS), Chennai, India.

Vedant Rungta (V)

William J. Clinton Foundation, New Delhi, India.

Yashika Bansal (Y)

William J. Clinton Foundation, New Delhi, India.

Jatin Chaudary (J)

The Humsafar Trust, Mumbai, India.

Vijay Yeldandi (V)

Society for Health Allied Research & Education India (SHARE India), Hyderabad, India.

Mahalingam Periasamy (M)

Society for Health Allied Research & Education India (SHARE India), Hyderabad, India.

Chengappa Uthappa (C)

Division of Global HIV and TB, Centres for Disease Control and Prevention (CDC), New Delhi, India.

Sudhir Chawla (S)

Division of Global HIV and TB, Centres for Disease Control and Prevention (CDC), New Delhi, India.

Sunita Upadhyaya (S)

Division of Global HIV and TB, Centres for Disease Control and Prevention (CDC), New Delhi, India.

Melissa Nyendak (M)

Division of Global HIV and TB, Centres for Disease Control and Prevention (CDC), New Delhi, India.

Venkatesan Chakrapani (V)

Centre for Sexuality and Health Research and Policy (C-SHaRP), Chennai, India.

Sheela Godbole (S)

Indian Council of Medical Research, National AIDS Research Institute (ICMR-NARI), Pune, India.

Vinita Verma (V)

National AIDS Control Organisation, Ministry of Health and Family Welfare, Government of India, New Delhi, India.

Bhawani Singh Kushwaha (B)

National AIDS Control Organisation, Ministry of Health and Family Welfare, Government of India, New Delhi, India.

Chinmoyee Das (C)

National AIDS Control Organisation, Ministry of Health and Family Welfare, Government of India, New Delhi, India.

Shobini Rajan (S)

National AIDS Control Organisation, Ministry of Health and Family Welfare, Government of India, New Delhi, India.

Anoop Kumar Puri (A)

National AIDS Control Organisation, Ministry of Health and Family Welfare, Government of India, New Delhi, India.

J V R Prasada Rao (JVR)

Former Health Secretary, Government of India, New Delhi, India.

Tarun Bhatnagar (T)

Indian Council of Medical Research, National Institute of Epidemiology (ICMR-NIE), Chennai, India.

D C S Reddy (DCS)

Independent Consultant, Lucknow, India.

Kimberly Green (K)

PATH, Hanoi, Vietnam.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH